NasdaqGS - Nasdaq Real Time Price USD
Xilio Therapeutics, Inc. (XLO)
0.8500
-0.3000
(-26.09%)
At close: May 14 at 4:00:00 PM EDT
0.8302
-0.02
(-2.33%)
After hours: May 14 at 7:58:57 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
71,075
--
139,165
218,060
Total Liabilities Net Minority Interest
53,477
--
33,518
32,631
Total Equity Gross Minority Interest
17,598
--
105,647
185,429
Total Capitalization
17,598
--
108,812
195,057
Common Stock Equity
17,598
--
105,647
185,429
Capital Lease Obligations
8,142
--
10,107
10,908
Net Tangible Assets
17,598
--
105,647
185,429
Working Capital
32,973
--
103,377
189,739
Invested Capital
17,598
--
115,479
195,057
Tangible Book Value
17,598
--
105,647
185,429
Total Debt
8,142
--
19,939
20,536
Share Issued
45,718.0520
27,607.6460
27,425.4470
27,358.3750
Ordinary Shares Number
45,718.0520
27,607.6460
27,425.4470
27,358.3750
12/31/2021 - 10/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNSP CNS Pharmaceuticals, Inc.
1.1500
-15.44%
CTMX CytomX Therapeutics, Inc.
2.3800
-4.80%
HCWB HCW Biologics Inc.
8.81
-12.34%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
TOVX Theriva Biologics, Inc.
0.5672
+1.29%
PLRZ Polyrizon Ltd.
0.0126
-55.79%
CRVS Corvus Pharmaceuticals, Inc.
3.6200
-6.94%
ZVSA ZyVersa Therapeutics, Inc.
0.5037
-2.76%
KTTA Pasithea Therapeutics Corp.
0.9552
+11.07%
SGMO Sangamo Therapeutics, Inc.
0.4380
-4.78%